BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21725288)

  • 21. Hypoxia and renal cell carcinoma: The influence of HIF1A+1772C/T functional genetic polymorphism on prognosis.
    Ferreira M; Teixeira A; Maurício J; Lobo F; Morais A; Medeiros R
    Urol Oncol; 2017 Aug; 35(8):532.e25-532.e30. PubMed ID: 28476527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma.
    Brunelli M; Eccher A; Gobbo S; Ficarra V; Novara G; Cossu-Rocca P; Bonetti F; Menestrina F; Cheng L; Eble JN; Martignoni G
    Mod Pathol; 2008 Jan; 21(1):1-6. PubMed ID: 17906617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosome 14q LOH in localized clear cell renal cell carcinoma.
    Mitsumori K; Kittleson JM; Itoh N; Delahunt B; Heathcott RW; Stewart JH; McCredie MR; Reeve AE
    J Pathol; 2002 Sep; 198(1):110-4. PubMed ID: 12210070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of chromosome arm 14q loss in nonpapillary renal cell carcinomas.
    Herbers J; Schullerus D; Müller H; Kenck C; Chudek J; Weimer J; Bugert P; Kovacs G
    Genes Chromosomes Cancer; 1997 May; 19(1):29-35. PubMed ID: 9135992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific genomic aberrations predict survival, but low mutation rate in cancer hot spots, in clear cell renal cell carcinoma.
    Köhn L; Svenson U; Ljungberg B; Roos G
    Appl Immunohistochem Mol Morphol; 2015; 23(5):334-42. PubMed ID: 24992170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma.
    An H; Xu L; Chang Y; Zhu Y; Yang Y; Chen L; Lin Z; Xu J
    Eur J Cancer; 2015 Sep; 51(14):1953-61. PubMed ID: 26188847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clear cell papillary renal cell carcinoma: a clinicopathological study emphasizing ultrastructural features and cytogenetic heterogeneity.
    Shi SS; Shen Q; Xia QY; Tu P; Shi QL; Zhou XJ; Rao Q
    Int J Clin Exp Pathol; 2013; 6(12):2936-42. PubMed ID: 24294381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of aberrant VHL/HIF pathway elements in predicting clinical outcome to pazopanib therapy in patients with metastatic clear-cell renal cell carcinoma.
    Choueiri TK; Fay AP; Gagnon R; Lin Y; Bahamon B; Brown V; Rosenberg JE; Hutson TE; Baker-Neblett KL; Carpenter C; Liu Y; Pandite L; Signoretti S
    Clin Cancer Res; 2013 Sep; 19(18):5218-26. PubMed ID: 23881929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
    Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
    Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery.
    El-Mokadem I; Fitzpatrick J; Bondad J; Rauchhaus P; Cunningham J; Pratt N; Fleming S; Nabi G
    Br J Cancer; 2014 Sep; 111(7):1381-90. PubMed ID: 25137021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibroblast activation protein predicts prognosis in clear cell renal cell carcinoma.
    López JI; Errarte P; Erramuzpe A; Guarch R; Cortés JM; Angulo JC; Pulido R; Irazusta J; Llarena R; Larrinaga G
    Hum Pathol; 2016 Aug; 54():100-5. PubMed ID: 27063470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monosomy of Chromosome 9 Is Associated With Higher Grade, Advanced Stage, and Adverse Outcome in Clear-cell Renal Cell Carcinoma.
    Nejati R; Wei S; Uzzo RG; Poureghbali S; Pei J; Talarchek JN; Ruth K; Dulaimi E; Kutikov A; Testa JR; Al-Saleem T
    Clin Genitourin Cancer; 2020 Feb; 18(1):56-61. PubMed ID: 31648964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting HIF2α translation with Tempol in VHL-deficient clear cell renal cell carcinoma.
    Sourbier C; Srivastava G; Ghosh MC; Ghosh S; Yang Y; Gupta G; Degraff W; Krishna MC; Mitchell JB; Rouault TA; Linehan WM
    Oncotarget; 2012 Nov; 3(11):1472-82. PubMed ID: 23178531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA profile in stage I clear cell renal cell carcinoma predicts progression to metastatic disease.
    Moynihan MJ; Sullivan TB; Burks E; Schober J; Calabrese M; Fredrick A; Kalantzakos T; Warrick J; Canes D; Raman JD; Rieger-Christ K
    Urol Oncol; 2020 Oct; 38(10):799.e11-799.e22. PubMed ID: 32534961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low CCL-21 expression associates with unfavorable postoperative prognosis of patients with metastatic renal cell carcinoma.
    Xiong Y; Liu L; Wang J; Xi W; Xia Y; Bai Q; Qu Y; Long Q; Xu J; Guo J
    Oncotarget; 2017 Apr; 8(15):25650-25659. PubMed ID: 27783999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD1d expression in renal cell carcinoma is associated with higher relapse rates, poorer cancer-specific and overall survival.
    Chong TW; Goh FY; Sim MY; Huang HH; Thike AA; Lim WK; Teh BT; Tan PH
    J Clin Pathol; 2015 Mar; 68(3):200-5. PubMed ID: 25477528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gain of chromosome 8q is associated with metastases and poor survival of patients with clear cell renal cell carcinoma.
    Klatte T; Kroeger N; Rampersaud EN; Birkhäuser FD; Logan JE; Sonn G; Riss J; Rao PN; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    Cancer; 2012 Dec; 118(23):5777-82. PubMed ID: 22605478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of various potential prognostic markers and survival data in clear cell renal cell carcinoma.
    Ebru T; Fulya OP; Hakan A; Vuslat YC; Necdet S; Nuray C; Filiz O
    Int Braz J Urol; 2017; 43(3):440-454. PubMed ID: 27583351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of 14q31-q32.2 in renal cell carcinoma is associated with high malignancy grade and poor survival.
    Alimov A; Sundelin B; Wang N; Larsson C; Bergerheim U
    Int J Oncol; 2004 Jul; 25(1):179-85. PubMed ID: 15202004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas.
    Béroud C; Fournet JC; Jeanpierre C; Droz D; Bouvier R; Froger D; Chrétien Y; Maréchal JM; Weissenbach J; Junien C
    Genes Chromosomes Cancer; 1996 Dec; 17(4):215-24. PubMed ID: 8946203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.